Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...

Cancer cells are pretty bold and clever—they hijack cellular survival and healing processes in order to fuel their growth, spread throughout the body, and ensure their own survival. The unfolded ...

The field of oncology research is increasingly focusing on understanding the tumor microenvironment (TME), particularly its implications for drug ...